IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $275,000 | +67.7% | 37,000 | +32.1% | 0.16% | +61.4% |
| Q3 2021 | $164,000 | -11.4% | 28,000 | 0.0% | 0.10% | -18.5% |
| Q2 2021 | $185,000 | -38.3% | 28,000 | -24.3% | 0.12% | -35.1% |
| Q1 2021 | $300,000 | +22.4% | 37,000 | -2.6% | 0.19% | +23.2% |
| Q4 2020 | $245,000 | +145.0% | 38,000 | +35.7% | 0.16% | +98.7% |
| Q3 2020 | $100,000 | -56.1% | 28,000 | -43.4% | 0.08% | -60.2% |
| Q2 2020 | $228,000 | +34.9% | 49,500 | 0.0% | 0.20% | +18.1% |
| Q1 2020 | $169,000 | -46.2% | 49,500 | -19.5% | 0.17% | -35.2% |
| Q4 2019 | $314,000 | +110.7% | 61,500 | 0.0% | 0.26% | +69.5% |
| Q3 2019 | $149,000 | -3.9% | 61,500 | -14.0% | 0.15% | +104.1% |
| Q2 2019 | $155,000 | -3.7% | 71,500 | +20.2% | 0.07% | +17.5% |
| Q1 2019 | $161,000 | -51.1% | 59,500 | -13.1% | 0.06% | -58.8% |
| Q4 2018 | $329,000 | -12.3% | 68,500 | +73.4% | 0.15% | +4.1% |
| Q3 2018 | $375,000 | -2.3% | 39,500 | 0.0% | 0.15% | 0.0% |
| Q2 2018 | $384,000 | – | 39,500 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |